Identifying Gene Targets in Breast Cancer Related to PI3K/mTOR Pathway
Author Information
Author(s): Heinonen Henna, Nieminen Anni, Saarela Matti, Kallioniemi Anne, Klefström Juha, Hautaniemi Sampsa, Monni Outi
Primary Institution: University of Helsinki
Hypothesis
The study aims to determine gene expression profiles dependent on the PI3K/mTOR/p70S6K pathway in breast cancer.
Conclusion
The identified downstream targets of p70S6K and the PI3K/mTOR pathway may have diagnostic value due to their association with aggressive breast cancer.
Supporting Evidence
- p70S6K is overexpressed in 10-30% of breast cancers.
- Silencing p70S6K altered the expression of 109 and 173 genes in two breast cancer cell lines.
- 17 genes showed overlap with genes differentially expressed after PI3K or mTOR inhibition.
Takeaway
Researchers looked at how certain genes change in breast cancer cells when a specific pathway is blocked, finding new potential targets for treatment.
Methodology
The study used microarrays and siRNA silencing to analyze gene expression in breast cancer cell lines treated with PI3K and mTOR inhibitors.
Limitations
The variability in gene expression changes may be due to different specificities and efficiencies of the treatments used.
Participant Demographics
The study involved five breast cancer cell lines with known gene copy number and expression alterations.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website